Compare SHASUN PHARMA with GSK Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHASUN PHARMA vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SHASUN PHARMA GSK PHARMA SHASUN PHARMA/
GSK PHARMA
 
P/E (TTM) x 123.9 52.3 237.0% View Chart
P/BV x 8.5 11.8 72.3% View Chart
Dividend Yield % 0.2 1.3 17.4%  

Financials

 SHASUN PHARMA   GSK PHARMA
EQUITY SHARE DATA
    SHASUN PHARMA
Mar-14
GSK PHARMA
Mar-19
SHASUN PHARMA/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs943,595 2.6%   
Low Rs461,253 3.6%   
Sales per share (Unadj.) Rs214.2184.7 116.0%  
Earnings per share (Unadj.) Rs5.326.3 20.3%  
Cash flow per share (Unadj.) Rs15.829.2 54.2%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %1.40.8 173.4%  
Book value per share (Unadj.) Rs53.3126.3 42.2%  
Shares outstanding (eoy) m56.62169.40 33.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.313.1 2.5%   
Avg P/E ratio x13.192.2 14.2%  
P/CF ratio (eoy) x4.483.1 5.3%  
Price / Book Value ratio x1.319.2 6.8%  
Dividend payout %18.776.1 24.6%   
Avg Mkt Cap Rs m3,958410,626 1.0%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m2,1645,372 40.3%   
Avg. sales/employee Rs ThNM6,306.7-  
Avg. wages/employee Rs ThNM1,083.1-  
Avg. net profit/employee Rs ThNM898.0-  
INCOME DATA
Net Sales Rs m12,12731,281 38.8%  
Other income Rs m2291,023 22.4%   
Total revenues Rs m12,35632,304 38.2%   
Gross profit Rs m1,0096,009 16.8%  
Depreciation Rs m594486 122.1%   
Interest Rs m4156 6,918.3%   
Profit before tax Rs m2306,540 3.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0287 0.0%   
Tax Rs m-732,373 -3.1%   
Profit after tax Rs m3024,454 6.8%  
Gross profit margin %8.319.2 43.3%  
Effective tax rate %-31.736.3 -87.3%   
Net profit margin %2.514.2 17.5%  
BALANCE SHEET DATA
Current assets Rs m6,88420,061 34.3%   
Current liabilities Rs m8,45614,543 58.1%   
Net working cap to sales %-13.017.6 -73.5%  
Current ratio x0.81.4 59.0%  
Inventory Days Days6257 108.6%  
Debtors Days Days10814 764.9%  
Net fixed assets Rs m4,97014,343 34.7%   
Share capital Rs m1131,694 6.7%   
"Free" reserves Rs m2,87519,704 14.6%   
Net worth Rs m3,02021,398 14.1%   
Long term debt Rs m1,8172 90,870.0%   
Total assets Rs m13,34739,113 34.1%  
Interest coverage x1.61,091.0 0.1%   
Debt to equity ratio x0.60 643,819.2%  
Sales to assets ratio x0.90.8 113.6%   
Return on assets %5.411.4 47.1%  
Return on equity %10.020.8 48.1%  
Return on capital %13.331.9 41.7%  
Exports to sales %46.40-   
Imports to sales %14.20-   
Exports (fob) Rs m5,622NA-   
Imports (cif) Rs m1,728NA-   
Fx inflow Rs m5,843534 1,094.1%   
Fx outflow Rs m2,1737,091 30.6%   
Net fx Rs m3,669-6,557 -56.0%   
CASH FLOW
From Operations Rs m3983,994 10.0%  
From Investments Rs m-1,635-1,433 114.1%  
From Financial Activity Rs m1,309-3,584 -36.5%  
Net Cashflow Rs m71-1,023 -7.0%  

Share Holding

Indian Promoters % 39.2 0.0 -  
Foreign collaborators % 0.0 50.7 -  
Indian inst/Mut Fund % 3.6 10.2 35.3%  
FIIs % 17.6 23.8 73.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 39.6 15.4 257.1%  
Shareholders   20,750 102,036 20.3%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SHASUN PHARMA With:   ALEMBIC PHARMA  STRIDES PHARMA SCIENCE  TTK HEALTHCARE  ASTRAZENECA PHARMA  BIOCON   

Compare SHASUN PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Asian Paints Rallies 7% Post Q4 Results(09:30 am)

Asian stock markets climbed today after US benchmarks halted a three-day slide, with signs of a strengthening labor market outweighing investors' concerns about rising inflation.

Related Views on News

GSK PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 124.4% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, GSK PHARMA has posted a net profit of Rs 2 bn (up 124.4% YoY). Sales on the other hand came in at Rs 9 bn (up 10.2% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY21); Net Profit Down 84.8% (Quarterly Result Update)

Oct 30, 2020 | Updated on Oct 30, 2020

For the quarter ended September 2020, GSK PHARMA has posted a net profit of Rs 765 m (down 84.8% YoY). Sales on the other hand came in at Rs 9 bn (down 0.3% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY21); Net Profit Down 2.2% (Quarterly Result Update)

Aug 26, 2020 | Updated on Aug 26, 2020

For the quarter ended June 2020, GSK PHARMA has posted a net profit of Rs 1 bn (down 2.2% YoY). Sales on the other hand came in at Rs 6 bn (down 17.7% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 398.9% (Quarterly Result Update)

Oct 25, 2019 | Updated on Oct 25, 2019

For the quarter ended September 2019, GSK PHARMA has posted a net profit of Rs 5 bn (up 398.9% YoY). Sales on the other hand came in at Rs 9 bn (up 8.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

GSK PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 28.1% (Quarterly Result Update)

Jul 24, 2019 | Updated on Jul 24, 2019

For the quarter ended June 2019, GSK PHARMA has posted a net profit of Rs 1 bn (up 28.1% YoY). Sales on the other hand came in at Rs 8 bn (up 7.1% YoY). Read on for a complete analysis of GSK PHARMA's quarterly results.

More Views on News

Most Popular

My Secret to Find Breakthrough Stocks(Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Worst Sector in the Market(Fast Profits Daily)

May 11, 2021

The worst sector in the stock market according to the charts.

The Key to Profit from India's EV Revolution(Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

SHASUN PHARMA SHARE PRICE


Nov 17, 2015 (Close)

TRACK SHASUN PHARMA

  • Track your investment in SHASUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SHASUN PHARMA - PANACEA BIOTECH COMPARISON

COMPARE SHASUN PHARMA WITH

MARKET STATS